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To what extent immune responses against the gut flora are compartmentalized within mucosal tissues in homeostatic 
conditions remains a much-debated issue. We describe here, based on an inducible AID fate-mapping mouse model, that 
systemic memory B cell subsets, including mainly IgM+ B cells in spleen, together with IgA+ plasma cells in spleen and bone 
marrow, are generated in mice in the absence of deliberate immunization. While the IgA component appears dependent on 
the gut flora, IgM memory B cells are still generated in germ-free mice, albeit to a reduced extent. Clonal relationships and 
renewal kinetics after anti-CD20 treatment reveal that this long-lasting splenic population is mainly sustained by output 
of B cell clones persisting in mucosal germinal centers. IgM-secreting hybridomas established from splenic IgM memory B 
cells showed reactivity against various bacterial isolates and endogenous retroviruses. Ongoing activation of B cells in gut-
associated lymphoid tissues thus generates a diversified systemic compartment showing long-lasting clonal persistence and 
protective capacity against systemic bacterial infections.
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Introduction
Gut microbiota triggers activation of multiple myeloid and lym-
phoid effector cells, which in turn prevent their systemic dissem-
ination. Symbiosis is achieved through local cues that contribute 
to the compartmentalization of mucosal immune responses and 
to the systemic ignorance of gut commensals in homeostatic con-
ditions (Belkaid and Hand, 2014).
Such a compartmentalization of immune responses occurs at 
first through the limited translocation of bacteria, sampled from 
the gut lumen either through dendritic cells carrying them to 
the mesenteric lymph node (MLN), or through M cell–mediated 
transcytosis in Peyer’s patches (PPs). The notion of “mesenteric 
firewall,” proposed by MacPherson et al., refers to such contain-
ment of the gut flora, restricting their dissemination and prevent-
ing a global activation of the systemic immune system outside 
inflammatory conditions (Hooper and Macpherson, 2010). Nev-
ertheless, multiple pieces of evidence have been brought recently 
indicating that bacterial products find their way to peripheral 
lymphoid organs and profoundly impinge on systemic immune 
activation. For what concerns B cells, short chain fatty acids, bac-
terial metabolites, or products of mucosal immune reactions has 
been described as global or antigen-specific modulators of IgA, 
IgM, or even IgG antibodies present in the general circulation 
(Proietti et al., 2014; Gomez de Agüero et al., 2016; Kim et al., 2016; 
Zeng et al., 2016).
Chronic activation of mucosal B cells takes place in PPs or 
isolated lymphoid follicles to fuel an IgA-secreting plasma cell 
compartment in the lamina propria. Such IgAs secreted in the 
gut lumen exert a potent barrier effect and, through their specific 
antigen recognition, can target distinct bacterial species, iden-
tified through their differential IgA coating (Palm et al., 2014; 
Bunker et al., 2015). The dependence of B cells from the systemic 
compartment, notably IgA plasma cells, on mucosal reactions has 
only recently started to be assessed. Circulating IgAs are reduced 
in germ-free mice, but such a reduction has been essentially 
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attributed to the massive reduction in the IgA-secreting plasma 
cell pool observed in the lamina propria (Lécuyer et al., 2014). 
IgA plasma cells emigrating from the gut have been identified in 
breast tissues during lactation, an occurrence that corresponds to 
a specific activation stage (Lindner et al., 2015), and antigen-spe-
cific IgA plasma cells have also been detected in bone marrow 
(BM) after mucosal immunization (Bemark et al., 2016; Lemke 
et al., 2016). In humans, in whom obviously inflammatory epi-
sodes cannot be excluded even in healthy subjects, IgA plasma 
cells with mucosal markers have been described in BM, and a 
residual IgA plasmablast population with similar markers has 
been observed in the blood upon rituximab treatment, suggest-
ing ongoing output from rituximab-resistant mucosal plasma cell 
progenitors (Mei et al., 2009, 2010).
The group of D. Allman recently reported the presence of 
BM IgA plasma cells harboring antibacterial specificity in the 
absence of external stimuli, a subset whose formation required 
the gut flora (Wilmore et al., 2018). Clonal relationships were also 
described between gut IgA plasma cells and spleen memory B cells 
(Lindner et al., 2015), indicating that such mucosal–peripheral 
crosstalk can take place in a homeostatic context. To more glob-
ally assess relationships of peripheral B cells to mucosal immune 
reactionsoutside inflammatory conditions or immunization, we 
used lineage tracing of AID-experienced cells, by marking B 
cells engaged in immune responses in a time-controlled manner 
(Dogan et al., 2009). We report here that in healthy, nonimmu-
nized mice raised in a clean animal facility, a long-lasting splenic 
IgM (and smaller IgA) compartment harboring mutated Ig genes 
and specificities against antigens from bacteria and endogenous 
retroviruses (ERVs) is maintained through the constant input of 
B cell clones persisting in PP germinal centers (GCs) and consti-
tutes a pool of preactivated B cells that can be rapidly mobilized 
upon infectious challenges.
Results
A persistent AID-labeled B cell population in 
nonimmunized mice
The AID-Cre-ERT2xROSA26-loxP-EYFP mouse (hereafter named 
AID-Cre-EYFP) allows the labeling of AID-expressing B cells 
upon tamoxifen feeding (Dogan et al., 2009). To evaluate the pos-
sible contribution of spontaneous/chronic immune reactions to 
the memory B cell pool, we used an experimental scheme of three 
tamoxifen ingestions, corresponding approximately to a 9–15-d 
labeling period (Fig. 1 A; Jarjour et al., 2014). A distinct B cell pop-
ulation was labeled over this time period and persisted several 
months after its initial formation, with little decay observed until 
1 yr in spleen and a twofold decay after 1 yr in PPs (Fig. 1 B). The 
frequency of EYFP+ labeled cells was highest in PPs (1–2% after 
3 mo compared with ∼0.2% in spleen), but total cell numbers 
were more important in spleen (133,000 ± 13,000 cells) than in 
PPs (60,000 ± 6,400), mesenteric lymph nodes (MLNs, 22,000 ± 
2,000), or BM (BM, 28,000 ± 2,900; Fig. 1 C). Very low numbers 
of EYFP+ cells were observed in other lymph nodes (inguinal or 
axillary), as well as in the circulation (Fig. S1 A). These num-
bers should be corrected for the labeling efficiency, as tamoxi-
fen only induces Cre-mediated EYFP+ expression in 20–50% of 
AID-expressing cells (Dogan et al., 2009; Tas et al., 2016). The 
persistent EYFP+ population comprised memory B cells and 
plasma cells in the spleen in an ∼4:1 ratio and in a reverse propor-
tion in BM (Fig. 1 D). Memory B cells were mainly IgM+ in spleen, 
with a smaller IgA fraction (Fig. 1 E). Other isotypes included 
IgG2b and IgG1, while very few cells expressed IgG3 and almost 
none expressed IgG2c (not shown). For plasma cells, IgA+ cells 
were more abundant and clearly dominated over other isotypes 
in BM (Fig. 1 F).
Insertion of the Cre recombinase disrupted the Aicda locus, 
making the reporter line haploinsufficient for AID. We therefore 
designed as control a reporter model in which the same targeting 
construct was used to modify a bacterial artificial chromosome 
(BAC) including 190 kb around the Aicda gene and obtained two 
transgenic lines with one copy each. EYFP-labeled B cell num-
bers were slightly, but not significantly, lower compared with the 
knock-in mouse, 3–5 mo after labeling, indicating that Aicda hap-
loinsufficiency has only a moderate impact on this AID-depen-
dent spontaneous response (Fig. S1 B). The knock-in AID-Cre-
EYFP mouse line, devoid of extra copies of linked genes present 
in the BAC construct, was therefore used throughout this study.
The endogenous response originates from GC B cells
Mouse transitional B cells have been described as expressing low 
but distinct levels of AID (Kuraoka et al., 2011), and we there-
fore studied at which stage of B cell development the Cre-ERT2 
enzyme was activated. To this end, we analyzed splenic B cells 
48  h after a single tamoxifen feeding in 2–3-mo-old animals. 
>75% of spleen EYFP+ B cells were GL7+, and almost all were 
PNA+ or CD95+ (Fig. 2, A and C). Localization of PNA+EYFP+ in 
GC structures was observed in both spleen and PPs (Fig. S2). We 
performed the same short-term labeling for 20-d-old animals, at 
which stage the vast majority of spleen B cells is composed of 
T1 and T2 immature B cells (Fig. 2 B). In these conditions, the 
EYFP labeling was minimal, clearly indicating that AID expres-
sion level at the transitional stage is insufficient to allow for Cre 
recombinase activity at the reporter locus (Fig. 2 B). EYFP label-
ing thus marks cells engaged in spontaneous/chronic GCs.
The follow up of GL7 labeling with time showed a decay of 
GL7+EYFP+ cells within a few days, indicating maturation of 
labeled cells in the spleen (Fig. 2 C, left). In contrast, analysis of 
PPs revealed a persistent EYFP+GL7+ population over one year, i.e., 
a long-lasting persistence of clones induced by chronic responses 
within GCs (Fig. 2 C, middle). Persistence of EYFP+ cells with a GC 
phenotype was also observed in MLNs (Fig. 2 C, right). Interest-
ingly, whereas GL7+ labeling dropped down rapidly in the spleen, 
the splenic EYFP+ memory population increased from day 12 to 
3 mo after labeling, at which time it reached a plateau (Fig. 1 B), 
suggesting that import from other sites of EYFP+ B cell formation 
may contribute to the accumulation of the splenic memory pool.
Mutations estimated on JH4 intronic sequences indicated a 
clear, but moderate mutation load in the IgM pool (0.62%), with 
27% of unmutated sequences in this AID-labeled subset and 
threefold higher mutation values for spleen IgA+ B cells (1.82%) in 
animals studied 3–5 mo after tamoxifen feeding (Fig. 2 E). Muta-
tion frequency increased from day 12 to 5 mo after labeling in 
the IgM+EYFP+ population (Fig. 2 D). The EYFP+B220+ population 
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represents thus antigen-experienced B cells, marked and diver-
sified by AID during activation in GCs.
A large IgM memory B cell pool accumulates with age and 
requires T cell– and TLR-dependent signals
Interestingly, all IgM+EYFP+ B cells harbored a double CD73+CD80+ 
phenotype, which has been described as the hallmark of mature 
memory B cells (Fig. 3 A; Taylor et al., 2012; Zuccarino-Catania 
et al., 2014). We took advantage of this phenotype to evaluate 
the size of the total, non-EYFP, IgM “memory” population in the 
spleen. By setting a gate on the EYFP+ population in a CD73/CD80 
FACS analysis, we could estimate the proportion of non-EYFP B 
cells in the same gate (Fig. 3 A). This CD73+CD80+IgM+ popula-
tion was then followed according to mouse age, and appeared to 
increase markedly up to 5 mo of age (6% of total B220+ B cells), 
while reaching progressively a plateau at later time points (7.9 
and 8.7% at 8 and 15 mo, respectively; Fig. 3 B). Mutations were 
analyzed in the total IgM+CD73+CD80+ population sorted with 
a preset gate on EYFP+ cells. The higher proportion of unmu-
tated sequences compared with the EYFP+IgM+ subset (Table 
S1) suggests that some naive B cells are included in this gate 
(∼25%), leading to a corresponding slight overestimation of the 
CD73+CD80+ B cell pool. When mutated sequences are consid-
ered, the mutation frequency was still slightly lower than the 
one of mutated sequences from the IgM+EYFP+ subset (0.66 vs. 
0.85%, Table S1 and Fig. 2 D).
Using a preset gate on EYFP+ B cells from a reference mouse, 
we also estimated the frequency of CD73+CD80+ B cells in CD3ε-, 
MyD88xTrif- and TLR7-deficient mice (Fig. 3 C), and compared 
it to wild-type mice. This population was impacted in all cases, 
most strongly in T cell deficient mice, indicating that both T 
cell and TLR-derived signals contribute to the formation of this 
mutated, memory-like subset.
We then analyzed the EYFP+ and EYFP− CD73+CD80+IgM+ pop-
ulation for a set of activation markers, chemokine receptors or 
integrins whose expression differed from naive B cells (Fig. 3 D). 
Both populations largely lacked CD23 expression, and showed 
reduced (but positive) CD21 expression levels compared with 
the naive subset. They showed a similar increased expression of 
activation markers like TIM-1 or PD-L1 and reduced expression 
of recirculation markers like CD62L or α4β7 integrins. CD11c was 
not markedly up-regulated, which, together with CD21, clearly 
distinguished these subsets from aged B cells (Hao et al., 2011; 
Rubtsov et al., 2011). EYFP+ and EYFP− subsets differed for other 
memory/activation markers, with higher expression of CD43, 
PD-L2 or TACI in EYFP+ B cells, as well as two integrins, α6 and 
β1, reported to mediate binding to the extracellular matrix in 
lymphoid tissues (Song et al., 2013). Altogether, the EYFP+ and 
EYFP− CD73 CD80 compartments share enhanced memory/acti-
vation marker expression compared with naive B cells, together 
with reduced hallmarks of recirculation and enhanced ones 
for residency, some of these features being more pronounced 
in EYFP+ B cells.
The endogenous response in spleen originates from B2 cells
B1 B cells are considered to be the main providers of natural anti-
bodies, and, more globally, to be spontaneously activated cells. 
Moreover, some markers observed on IgM+EYFP+ B cells, like 
CD43, are often used to identify B1 B cells in the spleen, and TIM-
1+ cells are enriched among CD5+ and regulatory B cells (Xiao et 
al., 2012). To ask whether the endogenous response observed is 
of B1 or B2 origin, we restored sublethally irradiated mice with 
i.v. injection of mixtures of cells from BM and peritoneal cavity, 
coming from wild-type or AID-Cre-EYFP mice in either of the 
two combinations (Fig. 4 A). Tamoxifen was given 6 wk after cell 
transfer and analysis performed 8 wk after tamoxifen labeling.
A large memory B cell subset was labeled when BM cells from 
AID-Cre-EYFP mice were used in the transfer, while minimal 
labeling was observed when the reporter line was used as source 
of peritoneal cavity B cells (Fig.  4  B). Interestingly, a distinct 
labeling of B1b cells in the peritoneal cavity was observed upon 
restoration with AID-Cre-EYFP BM cells and also in control AID-
Cre-EYFP fed with tamoxifen, indicating that a fraction of B1b 
cells can express AID (Fig. S3). The endogenous response thus 
appears to have mainly a B2 origin.
IgM diversification and switching to IgA requires the gut flora
The spontaneous appearance of EYFP+ B cells in the spleen com-
partment raises the question of their origin, and the mucosal 
lymphoid tissue, with its persistent GC clones appears as a pos-
sible candidate. We therefore studied the presence of EYFP+ in 
germ-free mice. Tamoxifen feeding proved to be not practicable, 
with systematic bacterial colonization of the gut observed after 
a few weeks. We therefore resorted to sterile, irradiated tamox-
ifen-containing food. A 2-wk feeding protocol was chosen as 
giving reasonable labeling efficiencies, albeit lower compared 
with three tamoxifen gavages. However, a large variability was 
observed between mice, possibly linked to the unpleasant taste of 
Figure 1. A spontaneous, persistent immune response in absence of deliberate immunization is observed in the AID-Cre-ERT2xROSA26-loxp-EYFP 
(“AID-Cre-EYFP”) reporter mouse upon tamoxifen ingestion. (A) A three tamoxifen feeding schedule, 5 d apart, was used to identify spontaneous AID-ex-
pressing cells in AID-Cre-EYFP mice. (B) Evolution of EYFP+ cell fraction with time in spleen and PPs. Time in months is ± 10 d, and in days refer to the first 
tamoxifen gavage (D0). (C) Total EYFP+ cell numbers per organ, 3 mo after the last tamoxifen ingestion, in spleen, PPs, MLNs, and BM (BM cell counts represent 
two femurs per animals and are thus a partial estimate of the total cell population). (D) Distribution of EYFP+ cells among B220+ and B220− subsets in spleen 
and BM, 3–4 mo after tamoxifen feeding. (E) Representative FACS profiles of heavy chain isotype distribution among spleen EYFP+ cells. Percentages are 
indicated for each panel, with values in brackets referring to the initial B220+EYFP+GL7− population. (F) IgM, IgA, IgG1, and IgG2b isotype distribution among 
spleen EYFP+ memory (B220+) and plasma cells (B220-) and BM B220− plasma cells, 3–4 mo after tamoxifen gavage. Intracellular staining was performed for 
plasma cells. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, one-way ANO VA with Holm-Sidak correction for multiple comparisons. Nonsignificant 
differences are not indicated. Mean values are indicated, with data from each individual mouse represented. Each analysis originates from two or more inde-
pendent tamoxifen-labeling experiments. See also Fig. S1.
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the food and its intermittent consumption. Conventional housed 
animals fed with the same diet were used as controls.
Total EYFP+ cell numbers were moderately, but significantly 
reduced in the spleen of germ-free mice, but the most drastic 
impact was on the IgA-positive subsets, both IgA memory and 
IgA plasma cells in spleen and BM (Fig.  5, A and B). For IgM 
subsets, a significant reduction in cell numbers was observed, 
and, most strikingly, in the mutation frequency of the IgH locus 
Figure 2. Kinetics of AID-dependent labeling within GCs show clonal persistence in PPs and MLNs and VH gene mutation accumulation in spleen. 
(A) GL7, PNA and CD95 phenotype of splenic B cells, 2 d after tamoxifen feeding. (B) Tamoxifen feeding of 20-d-old mice does not mark transitional B cells. 
Left, representative FACS profile of splenic B220+ cells from young mice (20-d-old), displaying a T1 (CD93+CD23−) and T2 (CD93+CD23+) phenotype. Right, 
total number of splenic EYFP+ cells, 2 d after a single tamoxifen ingestion in young (20 d old) versus adult mice. See also Fig. S2 (C). Fraction of EYFP+ with 
a GC phenotype as function of time after tamoxifen labeling. Left, spleen (day 0 corresponds to the first tamoxifen feeding, the 2d point thus corresponding 
to a single tamoxifen ingestion); middle, PP; right panel, comparison of different tissues, 3–4 mo after tamoxifen feeding. For the spleen panel, significant 
differences are only indicated for the first three time points. (D) Mutation frequency among splenic EYFP+ IgM+ B cells (rearranged intronic JH4 sequences), 
from mice analyzed at various time points after tamoxifen labeling. (E) Mutation frequency and distribution among splenic EYFP+ IgM+ and IgA+ subsets, from 
mice analyzed between 3 and5 mo after tamoxifen feeding. The total number of sequences is indicated in the pie chart, with a distribution of sequences with 
a given number of mutations. *, P < 0.05; **, P < 0.01; ****, P < 0.0001, Student's t test for panels B and E or one-way ANO VA with Holm-Sidak correction for 
panels with multiple comparisons. Mean values are indicated. All mice analyzed are represented and correspond to two or more independent experiments.
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Figure 3. A large mutated IgM B cell pool with memory marker expression accumulates with age in the spleen and shows T cell and TLR dependence. 
(A) Gating strategy used to defined the total IgM+CD73+CD80+ subset: a CD73+CD80+ gate including most EYFP+ cells is set on the B220+IgM+GL7−EYFP+ 
population (upper right), and then used to define the percentage of non-EYFP+ cells in this gate (lower right). (B) Evolution of the total IgM+CD73+CD80+ 
compartment with time (based on a gate set as defined in A). Ig gene mutations (rearranged intronic JH4 sequences) are shown in Table S1. (C) Frequency of 
IgM+CD73+CD80+ B cells in T cell and TLR-deficient backgrounds, compared with age-matched, 4-mo-old, wild-type, and AID-Cre-EYFP mice (with a preset 
gate on EYFP+B220+GL7−IgM+ cells from a parallel analysis). *, P < 0.05; **, P < 0.01, one-way ANO VA with Holm-Sidak correction. Mean values are indicated. 
Cumulative data of all analyzed animals are indicated. (D) Representative FACS profiles of naive (B220+IgM+EYFP−GL7−CD73−CD80−), B220+GL7−CD73+CD80+ 
EYFP+ and EYFP− subsets (gates represented in A [right], including for naive B cells).
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(Fig. 5 C), indicating that, whereas spontaneous AID activation 
still occurs in germ-free mice, the GC reaction that gives rise to 
EYFP+ B cells might be more transient. This differential mutation 
load was confirmed by VH sequencing of hybridomas generated 
from EYFP+IgM+ cells of conventional and germ-free mice (see 
below). Reduction of the total splenic pool of CD73+CD80+IgM+ 
B cells was accordingly observed (3.9 vs. 6.6%; Fig. 5 D). Thus, 
whereas splenic EYFP+IgM+ B cells are reduced but still generated 
in the absence of the gut flora, the low level of somatic diver-
sification observed suggests that their antigen specificity may 
differ (see below).
Similar clones contribute to the PP, splenic, and BM IgM/IgA 
memory and plasma cell pool
To delineate the relationships between the different compart-
ments, we sequenced different B cell subsets to uncover clones 
shared between them.
We isolated five different EYFP fractions from two mice, 1 yr 
after tamoxifen labeling: IgA memory B cells from PPs and IgM 
and IgA memory B cells, as well as IgA plasma cells from spleen 
and IgA plasma cells from BM. Approximately 60 sequences were 
obtained for each subset, i.e., 309 and 313 total sequences from 
each mouse. These 622 sequences segregated into 249 clones, 
with several showing considerable clonal expansion (a clone 
distribution per subset is represented in Fig. 6 A). Interestingly, 
in spite of the modest number of sequences collected from each 
subset, ∼12% of the clones observed comprised sequences origi-
nating from different tissues and/or harboring different isotypes. 
The clonal relationships observed are displayed in Fig. 6 B and 
concern all subsets, in various combinations, including clones 
present in three, four, or all subsets. Number of clonal relation-
ships observed are listed on the left side of Fig. 6 B, with numbers 
on the right side corresponding to the total number of two-by-
two relationships decomposed from clones comprising multiple 
subsets. Clonal overlap between the different tissues, irrespec-
tive of isotype or cell type, is depicted in Fig. 6 C.
These results strongly support a common origin of EYFP+ cells 
from these different tissues, isotypes, and differentiation stages.
Constant renewal from persistent clones rather than 
B cell longevity accounts for the persistence of EYFP+ 
cells in the spleen
The persistence of EYFP+ cells in PP GCs, the impact of the gut 
flora and the clonal relationships observed between PPs, spleen, 
Figure 4. The spontaneous immune response 
originates from B2, not B1 cells. (A) Scheme of 
restoration with cells from BM and peritoneal 
cavity from either wild-type or AID-Cre-EYFP 
origin after sublethal irradiation of the host and 
time frame of experiment. (B) Number of splenic 
EYFP+ cells per 106 lymphoid cells observed in 
restored animals, with tamoxifen-fed AID-Cre-
EYFP animals as controls (according to Fig. 1 A 
protocol). Data represent two separate experi-
ments; analysis performed at other time points 
gave similar results. See also Fig. S3. ***, P < 
0.001; ****, P < 0.0001.
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and BM EYFP+ cells suggest that constant output from mucosal 
tissues, rather than cell longevity, may account for the long-
term persistence of EYFP+ cells at the periphery. Such an obser-
vation was recently reported for lamina propria plasma cells, 
which were shown to be generated by memory B cell clones 
displaying longitudinal persistence and ongoing diversification 
(Lindner et al., 2015).
We used B cell depletion by anti-CD20 antibody to address this 
issue, taking advantage of the fact that anti-CD20 treatment in the 
mouse, as opposed to humans, is rather inefficient at depleting 
GC B cells (Baumjohann et al., 2013; Mahévas et al., 2013). We 
treated mice by three anti-CD20 injections 5 d apart, 1 mo after 
tamoxifen feeding (Fig. 7 A). Mice were analyzed either at day 
50, which represents the nadir of B cell depletion, or at day 90, 
at which time the B cell compartment is largely reconstituted. 
Accordingly, most EYFP+ B cells resisting anti-CD20 depletion at 
day 50 in PPs had a GC phenotype (Fig. 7 B, left; and Fig. 7 D), while 
EYFP+ cells surviving the treatment in the spleen were mainly 
B220− Blimp-1+ plasma cells (Fig. 7 C, left and middle; and Fig. 7 E). 
Rather strikingly, the restart of lymphopoiesis was accompanied 
by the reappearance of memory EYFP+ cells in spleen, and in PPs 
as well, consistent with a PP ongoing export upon termination of 
drug activity (Fig. 7, B and C, right; and Fig. 7, D and E).
To establish a more direct link between EYFP+ B cells from PPs 
and spleen through their clonal relationships, we sorted two dif-
ferent subsets from each tissue, from two different mice having 
their B cell compartment fully restored (at day 90 and 107 after 
the first anti-CD20 injection, respectively): GL7+ and GL7− B cells 
from PPs and IgA+ and IgA− B cells from spleen. A total of 261 VDJ 
sequences were obtained, segregating into 41 clones for spleen 
and 29 clones for PPs (Fig. S4), with 10 clones in common, i.e., 
∼1/3 and 1/4 of total clones from PPs and spleen, respectively. 
Clones shared between tissues involved the different subsets, 
IgA+ or IgA− and GL7+ or GL7− (Fig. 7 E). The splenic EYFP+ mem-
ory compartment is thus replenished after anti-CD20 treatment 
from mucosal B cells that resisted B cell depletion.
8 d of BrdU labeling was also performed, 2 mo after tamoxifen 
feeding, and EYFP+ cells were enriched by sorting, a procedure 
Figure 5. Memory IgM B cell diversification 
and switching to IgA requires the gut flora. 
Germ-free (GF) and control mice were given 
tamoxifen-containing food for 2 wk and analyzed 
2 mo after the treatment. (A) Analysis of total 
EYFP+ cells in spleen (top) and BM (bottom). (B) 
IgM and IgA isotype distribution among spleen 
EYFP+ B cells (B220+) and spleen and BM plasma 
cells (B220−). (C) Mutation frequency in heavy 
chain JH4 rearranged sequences from B220+Ig-
M+EYFP+ B cells from germ-free mice and con-
trol animals fed the same tamoxifen diet. (D) Per-
centage of CD73+CD80+ among total B220+IgM+ 
splenic B cells from germ-free mice and control 
animals fed the same tamoxifen diet. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001, Mann-Whitney test. 
Mean values are indicated. Animals from two dif-
ferent cohorts were analyzed.
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Figure 6. EYFP+ B cell clones are shared between PPs, spleen, and BM, as well as between IgA plasma cells and IgM and IgA memory B cells. EYFP+ PP 
IgA memory B cells, spleen IgA and IgM memory B cells, spleen and BM IgA+ plasma cells (PC) were isolated from two mice, one year after tamoxifen feeding, 
and rearranged JH4 sequences were determined and submitted to CDR3 clustering for clonal relationship analysis between these different subsets. (A) Clonal 
distribution within each subset. Each pie section represents one clone identified through its CDR3 junction, except for the white segment that represents all 
unique sequences. The total number of sequences and clones is indicated below each pie chart, and the clone size is color-coded for each subset as indicated on 
the right side. Nr, number. (B) Number and tissue/subset/isotype distribution of clones shared between different B cell and plasma cell subsets. The first 10 lines 
depict clones shared between two subsets, and the last six lines clones present in multiple subsets (not all possible configurations were observed). Numbers on 
the right side correspond to the sum of two-by-two relationships, including those observed in multiple clonal configurations. (C) Venn diagram of clones shared 
between spleen, PPs, and BM (the three subsets analyzed for spleen are pooled, thus slightly reducing the total number of splenic clones compared with A).
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Figure 7. Anti-CD20 depletion reveals the replenishment of the splenic EYFP+ pool from clones persisting within mucosal GC reactions. (A) Anti-CD20–
mediated depletion was performed by three injections, 5 d apart, 1 mo after tamoxifen labeling. (B and C) Analysis of PPs (B) and spleen (C) was performed on 
EYFP+ and EYFP− cells at day 50 after the first anti-CD20 injection, which represents the nadir of B cell depletion, and at day 90–107 (day 90), at which time 
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that allowed unambiguous identification of the lower level of 
EYFP fluorescence induced by the treatments required for BrdU 
staining (Fig. 8 A). A fraction of BrdU-labeled B cells was identi-
fied in the splenic EYFP+ compartment, for both plasma cells and 
memory B cells (16 and 26% for IgA− and IgA+ memory B cells, 
respectively, the former population being essentially IgM+, and 
27.5% for plasma cells; Fig. 8, B and C).
These two approaches clearly support the notion that constant 
input of persistent clones derived from mucosal immune reac-
tions still feed the IgM and IgA peripheral pool several months 
after their initial AID-dependent labeling.
Spleen EYFP+ IgM+ B cells show reactivity against commensal 
and infectious bacterial strains
To study the specificities of the IgM memory compartment, we 
took advantage of the two-step culture system of Nojima et al., 
which allows B cell proliferation with acquisition of a GC pheno-
type and, if pursued in presence of IL-21, plasma cell differen-
tiation (Nojima et al., 2011). 10-d cultures were used to test the 
specificities of secreted Ig present in the culture supernatant 
from spleen naive and EYFP+ B cells (50,000 sorted cells). Short-
term cultures (4 d with IL-4) were used to expand and activate 
EYFP+ cells for generating hybridomas. Two different cultures 
were made from two conventional mice, and used at both time 
points for supernatant analysis and hybridoma generation, with 
two hybridoma fusions performed independently. Three different 
cultures from three axenic mice were pooled in a single fusion, 
and two of them further maintained for collecting supernatants. 
38 hybridomas stably secreting IgM were generated from EYFP+ B 
cells of conventional mice, and 37 from germ-free mice.
Supernatants from bulk cultures or from individual hybrid-
omas were tested for their reactivity against luminal antigens (a 
global extract of intestinal content, including food and bacterial 
antigens), against defined human bacterial isolates representing 
equivalents of mouse commensal, opportunistic, and pathogenic 
species, as well as against mouse ERVs (isolated from the super-
natant of the Baki-1 cell line; Yu et al., 2012).
Strong reactivity was observed against luminal antigens for 
supernatants from conventional mice and much less so for germ-
free mice (Fig. 9 A). The profile of bacterial antigen recognition 
differed between conventional and germ-free mice, a pattern 
confirmed at the level of individual hybridomas (Fig. 9 B). Reac-
tivity against endogenous retroviral antigens was altogether low 
(shown as controls in Fig. 9 C).
Hybridomas showed different patterns of bacterial antigen 
recognition, linked or not with positivity for luminal antigens 
(Fig.  9  C). Several cases of reactivity against ERVs were also 
observed, but always cosegregated with a positive bacteria or 
luminal reaction. Recognition of multiple bacterial isolates 
suggested that common bacterial structures may be targeted. 
Moreover, hybridoma supernatants that recognized the eight 
bacterial species tested were also reactive against luminal con-
tent and ERVs, which could correspond to the recognition of 
conserved glycosylated motifs (e.g., E9). Interestingly, similar 
bacterial patterns could be observed that mobilized different 
VH genes (e.g., E9 and 1B5 from conventional mice, see Table S2) 
or the same VH with different junctions (e.g., H10 and 1G9) and 
originated in both cases from different animals. Altogether, 15 
out of 38 hybridomas from conventional mice showed positivity 
against the selected set of antigens (40%), and 10 out of 37 (27%) 
for germ-free mice (Fig. 9, C and D).
VH gene usage, N addition, CDR3 length, and mutation load 
were determined for each hybridoma with positive reactivity and 
listed in Table S2. The VH6-3 gene (J606 family) was frequently 
represented, with various junctions and mutation load. Six 
cases of identical clones, most likely generated by in vitro clonal 
expansion, were observed, which accordingly displayed similar 
recognition profile. The mutation load clearly differed between 
hybridomas from conventional and germ-free, while it was glob-
ally higher than in the JH4 intron sequence, possibly suggesting 
positive selection for mutation in functional VH genes.
Interestingly, bacterial recognition was shifted toward infec-
tious species (Citrobacter rodentium and Francisella tularensis) 
in hybridomas from germ-free mice (Fig. 9 D). This reactivity was 
mediated by different VH genes, including VH6-3, which, in A6 
hybridoma, was unmutated.
Supernatants from bulk cultures were also tested for their 
reactivity against autoantigens, using the autoantigen protein 
array at Southwestern University, Texas, and, apart from dsDNA, 
did not show consistent autoantigen recognition, and did not per-
form significantly better than supernatants from B1 cells (data 
not shown). Hybridoma supernatants were also tested for polyre-
activity, and no hybridoma showed corecognition of insulin and 
dsDNA (data not shown).
Early response of CD73+CD80+ B cells to bacterial challenge 
and protective capacity of their secreted IgM products
Reactivity against Klebsiella pneumoniae was observed in cul-
ture supernatants from both germ-free and conventional mice. 
We thus assessed whether CD73+CD80+ B cells would show spe-
cific mobilization upon inoculation of these bacteria. To avoid 
differentiation into GC or plasma cells that would alter their sur-
face phenotype and compromise their identification, we focused 
on the proliferation induced 3 d after bacterial injection (107 
the B cell compartment is largely restored. FACS profiles show that residual EYFP+ cells resisting the anti-CD20 treatment are mainly GC B cells in PPs (B, left) 
and plasma cells in the spleen, with a Blimp-1+ profile (C, left and middle), while EYFP+ memory B cells reemerge during reconstitution of the B cell pool in both 
spleen and PPs (B and C, right). (D) Percentage of B cells in PPs (left) and frequency of GC B cells among EYFP+ cells (right) at both time points. (E) Percentage 
of total (left part) and EYFP+ B cells (middle part) in spleen, with the percentage of plasma cells (B220−) among EYFP+ cells (right panel). (F) Clonal relationships 
observed among GL7+ and GL7− EYFP+ cells from PPs and IgA+ and IgA− EYFP+ splenic cells from two individual mice analyzed at day 90 and 107, respectively, 
after anti-CD20 treatment. Clonal distribution within the different subsets is represented in Fig. S4. The Venn diagram indicates the number of clones shared 
between both tissues. Mean values are represented. Each symbol represents an individual mouse. **, P < 0.01; ***, P < 0.001, Student's t test. Data are from 
three or more independent experiments.
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bacteria, intravenous injection). We used only CD73 as marker, 
because CD80 was not compatible with Ki67 staining. All mice 
survived the infection, and CD73+ B cells showed an increased 
frequency of Ki67 labeling, compared with control mice (20.6 vs. 
7.3%, Fig. 10, A and B) and to naive B cells from the same animals 
(1.2 and 2.3%; Fig. 10, A and B). The CD73+ compartment thus 
appears as an early responder during bacterial infection.
To test more directly the functional role of the IgM subset, 
we assessed the protective capacity of IgM secreted from bacte-
ria-reactive hybridoma against the same K. pneumoniae isolate. 
We injected purified IgM from two different hybridomas with 
similar recognition profile (500 µg of each C11 and 1G9 hybrid-
omas, i.p.) or from hybridomas without reactivity against these 
bacteria (2G3 and 1E9). The bacterial load was followed over 72 h 
in lung, kidney, liver, and spleen, with 10 mice analyzed at each 
time point in both settings. A significant difference in spleen and 
kidney was observed at 48 h between the groups injected with 
the bacteria-reactive antibodies or with antibody controls, with 
a reduction in bacterial load paralleling the overall level of infec-
tion. The bacterial load was also reduced in lung and liver, but 
the difference observed failed to reach significance (p-values of 
0.08 and 0.06 in lung and liver, respectively). The IgM memory 
pool thus harbors antigenic specificities that can, to some extent, 
impact infection with a pathogen through recognition of gut 
microbiota cross-reactive epitopes.
Discussion
We report here the description of a systemic memory population 
which is revealed during a 2-wk labeling period through its EYFP 
expression triggered by a tamoxifen-inducible Cre recombinase 
controlled by the Aicda promoter (Dogan et al., 2009). This B 
cell population was observed in the absence of deliberate immu-
nization, persisted over 1 yr and displayed mutated Ig genes. It 
consists in spleen of a major IgM memory subset, including also 
IgA memory B cells, as well as a smaller subset of IgA and IgM 
plasma cells. In BM, IgA plasma cells predominate, together with 
a smaller subset of IgM-secreting cells.
AID-dependent labeling was acquired during activation in 
spontaneous GC in spleen, PPs, and MLNs. Rather remarkably, 
EYFP labeling of GC B cells remained for up to one year in PPs, 
while it waned in the spleen after 2 wk. Persistence of the EYFP+ 
splenic population appeared surprisingly to be achieved, not 
through its specific longevity, but through dynamic replenish-
ment from B cell clones persisting in GCs from PPs. This was 
demonstrated by three convergent approaches: first, by Ig gene 
sequencing performed on different EYFP+ B cell subsets which 
allowed the identification of clonal relationships between cells 
from different tissues (PPs, spleen, and BM), isotypes (IgM and 
IgA), and differentiation stage (memory B cells and plasma cells); 
second, by BrdU labeling experiments, which showed a con-
stant input of EYFP-marked, B cells in the spleen; and finally by 
anti-CD20 mediated B cell depletion, which put in evidence, upon 
termination of drug activity, the reconstitution of the splenic 
memory pool from PP GC EYFP+ B cells that escaped deletion.
All AID-labeled cells harbored a CD73+CD80+ phenotype, 
markers that have been linked previously with a mature memory 
Figure 8. BrdU labeling shows ongoing replenishment of the EYFP+ 
splenic subset. (A) An 8-d BrdU pulse, 2 mo after tamoxifen labeling was 
performed. EYFP+ cells were enriched by prior sorting (top panel, left), to allow 
for a clear distinction of EYFP-positive and -negative subsets after treatment 
for BrdU staining, and EYFP+B220+ (IgA+ or IgA−) and B220− subsets were ana-
lyzed. (B) Representative FACS profile of the fraction of BrdU-positive cells in 
the different fractions identified in A. (C) Analysis of the BrdU+ fraction from 
4 mice, with the different subsets of each individual mouse represented by 
the same symbol. Mean values are represented. The data shown correspond 
to one experiment out of two performed in similar conditions. **, P < 0.01, 
one-way ANO VA with Holm-Sidak correction.
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phenotype (Taylor et al., 2012; Zuccarino-Catania et al., 2014), 
together with other activation/memory markers like CD43, 
TACI, TIM-1, PD-L1, and, more heterogeneously, PD-L2, as well 
as “resident-type” integrins, like CD49f (Itga6) and CD29 (Itgb1). 
We therefore used these CD73+CD80+ markers to estimate the 
size of the total IgM+ memory subset in the mouse spleen. The 
IgM+CD73+CD80+ population reaches a plateau around 5 mo of 
age to ∼4% of the total splenic B cell pool and displays a muta-
tion load comparable to the B220+EYFP+ subset. This CD73+CD80+ 
subset was markedly impacted in T cell–deficient animals, and 
also reduced in MyD88xTrif and TLR7-deficient mice. It should 
be stressed, however, that while our EYFP labeling procedure 
allows us to follow cell populations that are long-lasting either 
by being long-lived or renewed from persistent clones, additional 
Figure 9. Specificity of IgM memory B cells from conventional and germ-free mice. The specificity of EYFP+ IgM memory B cells was assayed from bulk 
culture supernatants from either in vitro differentiated B cells or from individual hybridomas. (A) EYFP+IgM+ B cells from either conventional or germ-free 
mice were activated in vitro in the culture conditions of Nojima et al. (2011) (in presence of CD40L, BAFF, IL4 and IL21) and the supernatant tested by ELI SA 
at day 10 against the gut luminal content, with supernatants from naive B cells as control. (B) The same supernatants (N1 and N2: naive B cells) were tested 
against a panel of eight human bacterial isolates, representing equivalents of mouse commensals or pathogens. (C and D) Hybridoma supernatants obtained 
from fusions performed on similar cultures at day 4 after activation of EYFP+ cells were tested by ELI SA against gut luminal content, human bacterial isolates 
(same bacterial panel as in B) and supernatants from the ERV-producing Baki1 cell line. (C) Conventional mice. (D) Germ-free mice. The horizontal line marks 
background signal. YFP-1 and YFP-2 correspond to supernatants from day 10 cultures. Two different fusions were performed for EYFP+ B cells from two different 
conventional mice and one fusion from three germ-free mice.
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immune reactions clearly contribute to the splenic C73+CD80+ 
IgM+ B cell pool without displaying such features (Fig. S5). Spon-
taneous splenic GCs have been previously described by the group 
of Rahman, who showed that they depended on IFNγ–IFNγR and 
TLR7 signaling and produced essentially IgG2b and IgG2c (Soni 
et al., 2014; Domeier et al., 2016). The plateau observed for the 
CD73+CD80+ population is thus likely to involve a global main-
tenance of the pool, with constant input and cell death from 
GALT-derived persistent clones, but also newly activated ones 
from spontaneous splenic GC, which fail to show clonal per-
sistence. Some of the phenotypic differences observed between 
the EYFP+ and EYFP− CD73+CD80+ splenic compartment (for, e.g., 
CD43 or PD-L2 expression) could correspond to the mixed origin 
of the splenic EYFP− IgM memory pool.
Our study extends to the systemic immune system the 
observation of Pabst et al. of the longitudinal persistence of 
B cell clones feeding mucosal plasma cells from ongoing PP 
immune responses (Lindner et al., 2015). It clearly documents 
the contribution of such mucosal-derived effector B cells com-
prising large expanded clones, not only to the peripheral IgA 
plasma cell pool, but also to memory B cells including a major 
splenic IgM population. The IgM compartment is still present, 
albeit reduced, in germ-free mice, while both IgA memory and 
plasma cells are drastically affected. Dependence of the BM IgA 
Figure 10. Early response of the IgM+CD73+ subset to bacterial challenge. (A) Mice were challenged with i.v. injection of 107 K. pneumoniae, and Ki67 
labeling of spleen cells was performed 3 d after and compared with noninfected mice (controls). Top part, representative FACS profile of Ki67 labeling percentage 
among naive and total CD73+ B cells (B220+-gated) from infected mice and controls. Bottom part, Ki67 labeling percentage among total naive and CD73+ spleen 
B cells from K. pneumoniae–infected or control mice. ****, P < 0.0001, one-way ANO VA with Holm-Sidak correction. Mean values are indicated. Results shown 
correspond to two different experiments. (B) Mice were injected i.p. with purified IgM from C11 and 1G9 hybridomas (500 µg each, with anti–K. pneumoniae 
reactivity, see Fig. 9 C) or from 1E9 and 2G3 hybridomas as control. 107 K. pneumoniae were injected i.p. 1 h later, and bacterial load followed over 72 h in kidney, 
lung, spleen, and liver. Five animals were analyzed in each group for each time point. Animals from two different cohorts were pooled for analysis. Mean values 
± SEM are indicated. **, P < 0.01, Mann-Whitney test.
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plasma cell pool upon the gut flora has been recently reported 
by Wilmore et al. (2018). IgM memory B cells observed in the 
spleen of germ-free animals display a lower mutation load, 
suggesting that residual antigen activation in the gut, possibly 
through food antigens or endogenous triggers like ERVs, may 
not sustain mutation accumulation.
The antigen specificity of the spleen IgM+EYFP+ compart-
ment, studied from supernatants of in vitro B cell cultures, as 
well as through the establishment of hybridomas, showed a broad 
cross-reactivity against antigens from the gut luminal content 
(which includes both commensals and food antigens), against 
multiple types of bacteria, as well as against ERVs. This indicates 
that recognition for common bacterial motifs, possibly glycan 
epitopes (Patel and Kearney, 2016), are preferentially selected in 
the systemic IgM memory pool. It should be noted accordingly 
that no unique reactivity against ERVs was observed, as it was 
always linked with bacterial or luminal content recognition, fur-
ther documenting the cross-reactivity of these IgM antibodies. 
Interestingly, TLR7 is also a key element of the immune response 
against ERVs and bacterial products are important drivers of 
their expression (Yu et al., 2012; Young et al., 2014). A large frac-
tion of hybridomas from germ-free mice still showed reactivity 
against these three categories of antigens, with a different pro-
file for bacterial isolates, notably a preferential recognition of 
pathogenic species like Francisella tularensis. Moreover, due 
to the much lower mutation frequency observed in germ-free 
conditions, bacterial recognition was achieved in some cases by 
unmutated VH genes (e.g., V6.3 of the J606 family), thus revealing 
new cases of germline-encoded antibacterial reactivity in the V 
gene repertoire.
Natural IgMs have multiple roles in immune homeostasis, 
from scavengers to protection against autoimmune processes 
(Ehrenstein and Notley, 2010). Their critical role in infectious 
processes has also been reported (Ochsenbein et al., 1999). B1 
cells are important contributors of these spontaneously arising 
antibodies, but they are clearly not the sole source of circulating 
IgMs (Thurnheer et al., 2003; Reynolds et al., 2015). The moni-
toring of somatic mutation at the protein level has revealed that 
mutated IgMs accumulated with age in nonimmunized animals 
(Williams et al., 2000), an observation that clearly matches our 
description of a mutated IgM memory subset in the absence of 
external challenge. The broad antibacterial recognition profile 
identified within this subset suggests that, in addition to B1 B 
cell–derived antibodies, mutated IgM antibodies may represent 
an additional line of defense, affording a protection against sys-
temic microbial translocation, a process that takes place in both 
healthy and pathological contexts (Brenchley and Douek, 2012), 
or external bacterial aggressions.
This work thus describes a new layer of B cell memory, main-
tained through ongoing renewal of persistent clones diversifying 
in the gut and thereafter reaching the systemic immune compart-
ment, where they can be activated by cognate or cross-reactive 
antigens. It has been recently proposed that the gut microbiota 
may also shape the preimmune repertoire (Chen et al., 2018). 
Nevertheless, the memory IgM subset we describe clearly stands 
out as a more rapid responder to bacterial challenge, compared 
with naive B cells.
IgM memory B cells have emerged as integral effectors of recall 
immune responses in the mouse (Dogan et al., 2009; Zuccarino-
Catania et al., 2014; Krishnamurty et al., 2016). Mutated IgM B 
cells represent a large subset in humans as well, but their origin, 
function, and diversification is still a matter of debate. It will be 
obviously not possible to identify a pool of activated B cells gener-
ated in the absence of external challenge, but the contribution of 
IgM B cell clones activated in the gut to the peripheral B cell rep-
ertoire is a more testable question, and recognition of common 
bacterial epitopes has already been suggested for some human 
memory subsets, like marginal zone or CD27−IgD− B cells (Puga 
et al., 2012; Berkowska et al., 2015). Very recently, Wardemann 
et al. described in human blood the presence of IgM memory B 
cells specific for K. pneumoniae LPS glycan antigens, cells that 
harbor clonal relationships with plasma cells from the lamina 
propria and display cross-specificity for various bacterial com-
mensal species as well as for HIV gp140 glycoprotein (Rollenske 
et al., 2018). This study deepens the link previously reported 
between reactivity against epitopes of the gut flora and antiviral 
responses (Trama et al., 2014; Williams et al., 2015), and strongly 
supports the proposition of a protective role afforded by systemic 
IgM memory B cells recognizing epitopes shared between muco-
sal symbionts, pathobionts, and overt pathogens.
Materials and methods
Mouse lines
Heterozygous AID reporter mice were generated by breeding 
AID-Cre-ERT2 mice with the ROSA26-loxP-EYFP reporter mice 
(Dogan et al., 2009) and are named “AID-Cre-EYFP” throughout 
this paper. The Aicda and ROSA26 loci are tightly linked on chro-
mosome 6, and the line used was isolated from a recombination 
event that brought both reporters on the same chromosome.
MyD88xTrif-deficient mice were kindly given by Catherine 
Werts and Ivo Gomperts Boneca (Institut Pasteur, Paris, France), 
CD3ε KO mice by Sophie Ezine (INEM, Paris, France), and 
TLR7-deficient mice by Isabelle Cremer (Centre de Recherche 
des Cordeliers, Paris, France). All gene-targeted mice were ana-
lyzed between 5 and 6 mo of age. AID-Cre-EYFP mice were ren-
dered axenic by cesarean transfer at the CDTA (Orléans, France) 
and checked regularly for lack of bacterial colonization (under 
the supervision of Alexandre Diet, coordinator, and Cécile Fré-
mond, veterinary).
All mouse experimental protocols have been approved by the 
Paris Descartes Ethics Committee and authorized by the French 
Ministery of Research.
Generation of the BAC AID-Cre-ERT2 mouse line
To avoid Aicda haploinsufficiency linked with targeted inser-
tion of the Cre-ERT2 gene at the Aicda locus, we generated a 
line in which the same targeting event was achieved within a 
bacterial artificial chromosome. DNA from AID-Cre-ERT2 mice 
was used to amplify a 6-kb Cre-ERT2 fragment flanked with 
2-kb sequences from the Aicda locus, cloned in vector pLD53 
(gift of Nina Papavassiliou, Rockefeller University, New York, 
NY) and transformed into PIR2 One Shot competent bacte-
ria (Invitrogen). The RP24-68I7 BAC strain (sequence NCBI 
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AC158651) that include 190 kb of the Aicda locus was obtained 
from BAC PAC resources (Children’s Hospital Oakland Research 
Institute, Oakland, CA) and the pSV1-RecA vector containing 
the AID-Cre-ERT2 insert vector was used to promote homolo-
gous recombination by successive selection steps according to 
(Misulovin et al., 2001). The BAC DNA was extracted according 
to the Transgenic Animal Web protocol and microinjected into 
C57BL/6 fertilized eggs. Two independent mouse lines con-
taining each a single BAC copy were obtained and gave similar 
EYFP-labeling profiles.
Tamoxifen regimen
Doses of 10 mg Nolvadex (AstraZeneca) in 500 µl of 20% Clin-
oleic (Baxter) were administered by gavage every 5 d for three 
times (day 0, 5, and 10). Tamoxifen experiments with young 
versus adult mice were done with a single dose of tamoxifen. 
Here the amount of tamoxifen was adjusted to the weight of 
animal for young mice. Axenic mice received an irradiated 
tamoxifen diet during 2 wk (400 mg tamoxifen citrate/kg 
diet; TD55125I; Harlan Laboratories Europe), and control mice 
were fed similarly.
Confocal microscopy
8-µm cryosections were prepared from spleen and PPs fixed 
with 4% paraformaldehyde (PFA) and dehydrated overnight in 
30% sucrose before freezing in optimal cutting temperature 
compound. For immunostaining, samples were saturated with 
PBS supplemented with 10% (vol/vol) goat serum, labeled with 
primary antibodies and secondary reagents (listed in Table S3) in 
PBS supplemented with 0.5% BSA, mounted with Fluoromount 
(Southern Biotechnology Associates) and analyzed with a Leica 
TCS SP8 STED confocal microscope.
Flow cytometry analysis and cell sorting
Splenic populations were separated using a FAC SAria cell sorter 
(BD Biosciences) for cell culture experiments. Splenic subsets 
were also sorted for the analysis of mutations in the rearranged 
JH4 intronic sequences of the IgH locus. For flow cytometry anal-
ysis, cell suspensions of spleen, PPs, lymph nodes, and other 
tissues were incubated on ice for 20 min with combinations 
of fluorochrome-conjugated antibodies in PBS supplemented 
with 0.5% BSA. Red blood cells from lymphoid tissues (spleen 
and BM) were lysed before staining. When necessary, cells were 
stained by PeCy7-conjugated streptavidin as secondary reagent. 
Antibodies used in this study are summarized in Table S3. Dead 
cells were excluded by using 7-aminoactinomycin D staining in 
the analysis. For intracellular isotypes and Blimp-1 staining, cells 
were first stained for surface antigens, then fixed, and perme-
abilized with Cytofix/Cytoperm solution (BD Biosciences). For 
Ki67 labeling, cells were fixed in 4% PFA (20 min at 4°C) and 
permeabilized in 0.5% Triton X-100 (20 min, room tempera-
ture). Cells were then washed and stained for Ki67 in 0.5% Triton 
X-100. After washing, cells were resuspended in PBS containing 
2% FCS and collected on BDL SR Fortessa apparatus. Analyses 
were done with FlowJo (Tree Star Inc.) or Diva (Becton Dick-
inson) softwares.
Adoptive cell transfer
3 × 106 total cells from peritoneal cavity as source of B-1 cells and 
3 × 106 total cells from BM as source of B-2 cells in 200 µl PBS 
were injected intravenously in recipient mice that have been 
sublethally irradiated with 8.5 Gy 12 h before, according to the 
protocol described in Baumgarth et al. (1999). Recipient mice 
received three doses of tamoxifen 6 wk after cell injection and 
were analyzed 8 wk after the last tamoxifen.
In vitro B cell cultures and supernatant collection
Purified splenic naive B cells and splenic EYFP+ memory B cells 
(5 × 104 cells per well; Nojima et al., 2011) were cultured in 6-well 
plates in the presence of 3T3 40LB cells (3 × 105 cells per well) 
that had been pretreated with mitomycin C (1 mg/ml during 3 h; 
Sigma) in 8 ml RPMI-1640 medium supplemented with 10% FCS, 
5.5 × 10−5  M 2-mercaptoethanol, 10  mM Hepes, 1  mM sodium 
pyruvate, 100 U/ml penicillin, and 100 µg/ml streptomycin (GIB 
CO). rIL-4 (1 ng/ml; Peprotech) was added to the primary cul-
ture for 4 d. On day 4, the cells were replated (5 × 105 cells) onto 
a new feeder layer treated with mitomycin C (3 × 106 cells) in a 
10-cm tissue culture dish and cultured in 40 ml of medium sup-
plemented with rIL-21 (10 ng/ml, Peprotech) for 6 d. Cells were 
cultured in a humidified atmosphere at 37°C with 5% CO2. At day 
10, 38 ml of supernatant were collected and concentrated using 
an Amicon Ultra 100000 MCWO (Millipore).
EYFP Hybridomas generation
5 × 104 sorted splenic memory EYFP+ B cells were amplified 
during 4 d on the 3T3 40LB feeder layer in presence of IL-4. EYFP+ 
cells were added to Sp2/0 myeloma cell line in a ratio 1:1. Mixed 
cells were washed three times in DMEM and then cells were 
fused using the ClonaCell-HY hybridoma kit (StemCell Technol-
ogies, Inc.; Le Gallou et al., 2017).
Analysis of mutations in the JH4 intronic sequence of the IgH 
locus and rearranged VH genes of hybridomas 
The JH4 intronic sequence flanking rearranged VH gene segments 
was amplified by PCR from DNA of sorted B cell subsets, from 
10,000 to 1,000 cells. The PCR primers used are in 5′, a mixture of 
eight FR3 primers amplifying most VH gene families (VH1: 5′-GAG 
GAC TCT GCR GTC TAT TWC TG-3′, VH3: 5′- GAG GAC ACA CCC ACA 
TAT TAC TG-3′, VH5: 5′-GAG GAC ACR GCC ATG TAT TAC TG-3′, VH6: 
5′-GAA GAC ACT GGA ATT TAT TAC TG-3′, VH7: 5′-GAG GAC AGT GCC 
ACT TAT TAC TG-3′, VH9: 5′-ATG AGG ACA TGG CTA CAT ATT TC-3′, 
VH10/12: 5′-GAG GAC ACA GCC ATG TAT TAC TG-3′, VH11: 5′-GAG 
GAC ACA GCC ACG TAT TTC TG-5′, in a 6:1:3:1:1:1:1:1 ratio); in 3′, a 
JH4 intronic primer (JH4rev: 5′-CAC CAG ACC TCT CTA GAC AGC-
3′), with a nested amplification performed in cases of low cell 
numbers (using JH4-nested: 5′-TGA GAC CGA GGC TAG ATG CC-3′ 
and the same VH primer set; 2 min at 98°C and 40–50 cycles of 
15 s at 98°C, 30 s at 64°C and 30 s at 72°C, with Phusion DNA poly-
merase [New England Biolabs]; and 30 additional cycles in cases 
of nested PCR). PCR products were cloned with the Zero Blunt 
cloning kit (Invitrogen) and sequences were determined with an 
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ABI Prism 3130xl Genetic Analyzer. Mutations were identified 
within 448 bp of the JH4 intron and analyzed with the help of the 
CodonCodeAligner software. Between 25 and 96 sequences per 
sample were determined for mutation frequency determination. 
Clonal relationships were established using CodonCodeAligner, 
plus manual inspection, notably to discard clonal relationships 
that would include sequence changes at the V-D or D-J junction.
For hybridoma sequences, total RNA was isolated with the 
RNeasy Micro kit (QIA GEN) and reverse transcribed by random 
priming with the Affinityscript Multiple Temperature cDNA 
synthesis kit (Agilent Technologies). The following primers 
amplifying VH1, VH3, VH5, VH11 and VH12 families (in a 5:1.5:1.5:1:1 
ratio), together with a reverse Cµ primer were used for amplifi-
cation: mVH1, 5′-AGG TYC AGC TGC ARC AGT CT-3′; mVH3, 5′-GTG 
CAG CTT CAG GAG TCAG-3′; mVH5, 5′-GAA GTG AAG CTG GTG GAG 
TC-3′; mVH11, 5′-ATG GAG TGG GAA CTG ATC TTA-3′; mVH12, 5′-AGC 
TTC AGG AGT CAG GACC-3′; Cµ, 5′-CAT GGC CAC CAG ATT CTT ATC-
3′. PCR amplification conditions were 94°C 45 s, 62°C 1 min, and 
72°C 1.5 min for 35 cycles with GoTaq polymerase (Promega), and 
20 pmol of primers. PCR products were gel-purified and 50 ng 
were sequenced with the Cµ primer.
BrdU labeling
Cell proliferation was assessed 2–3 mo after tamoxifen labeling. 
BrdU was given at 0.8 mg/ml in the drinking water for 8 d, with 
water supply changed every day. Splenic cell suspensions were 
stained with the desired antibodies (B220, IgA, GL7) and the 
LIVE/DEAD Fixable Aqua Amcyan Dead Cell Stain kit was used 
for gating out dead cells. Fixation with cytofix/cytoperm buffer 
(BrdU APC kit, Beckton Dickinson) was performed before enrich-
ment of EYFP+ cells by cell sorting. This enrichment procedure 
allows the correct identification of EYFP+ cells after the BrdU 
staining procedure that lowers the EYFP signal, while keeping 
sufficiently EYFP− cells for internal control. BrdU staining was 
performed on sorted cells (8–15 × 104 cells) after fixation and 
permeabilization using the BrdU APC kit, according to the con-
ditions of the supplier, with adaptation of the protocol for low 
cell numbers (anti-BrdU-APC antibody diluted 1/150e in 50 µl for 
∼10 × 104cells).
Anti-CD20 depletion
B cell depletion was performed by three injections, 5 d apart, of 
the 18B12 anti-CD20 antibody, 1 mo after tamoxifen labeling (250 
µg per injection, i.p., mouse IgG2a, Biogen Idec). PP and spleen 
lymphocytes were analyzed at day 50 (nadir) or day 90–107. 
The efficiency of B cell depletion was checked on blood for all 
animals at day 50.
ELI SA
Antibody concentrations in supernatants were determined by 
anti-mouse IgM ELI SA using mouse monoclonal IgM as standard 
(Sigma). Supernatants were used at 1 µg/ml. For detection of IgM 
against bacteria, bacteria from human clinical isolates were pre-
pared by overnight cultures on LB agar Petri dishes. 10 µl was 
harvested using a sterile inoculating loop and resuspended in 1 ml 
of PBS. Lysis of bacteria was performed in a FastPrep instrument 
(three runs of 45 s at a setting of 6), followed by centrifugation (5 
min at 12,000 g). To ensure that no live bacteria remained, pellets 
were resuspended in PBS and incubated 30 min at RT with 10 
µg/ml of polymyxin B (for Pseudomonas aeruginosa, Escherichia 
coli, K. pneumoniae, Salmonella enterica, Enterobacter cloacae, 
Citrobacter rodentium, and Francisella tularensis) or vancomy-
cin (Staphylococcus aureus) before plating aliquots on LB agar. 
Killed bacteria were coated at 5 µg/ml. ELI SAs were performed 
as above and OD was read at 450 nm.
For detection of antiendogenous retroviral specificities, 
ERVs purified from supernatants of Baki-1 cell line according 
to Yu et al. (2012), were used at 5 µg/ml in PBS for coating in 
96-well plates.
In vivo infection
K. pneumoniae (strain KP B13E6, used for hybridoma superna-
tant assays) was grown in LB to exponential growth phase and 
diluted to the appropriate concentrations in saline solution (0.9% 
wt/vol of NaCl). 107 bacteria were injected i.v. for proliferation 
assays of CD73+ cells. To test for their protective capacity, IgM 
were purified from supernatants of hybridoma cultures per-
formed in endotoxin-free conditions by ion exchange chroma-
tography (RD Biotech). Two groups of 6–8-wk-old female BALB/c 
mice (Janvier) were pretreated with MAbs, 4 h before challenge: 
one group was injected i.p. with 1 ml of a 1/1 mixture of bacte-
ria-reactive MAbs (hybridoma C11 and 1G9 at a final concentra-
tion of 1mg/ml); and a control group was injected i.p. with 1 ml of 
a 1/1 mixture of control MAbs (hybridomas 2G3 and 1E9, 1mg/ml 
final). Mice were then i.p. inoculated with 200 µl of a bacterial 
suspension containing 1.2 × 107 CFUs per mouse. Inoculum titers 
were checked by spreading dilutions of the preparations on LB 
agar plates. Two groups of five mice were analyzed for each time 
point for each group, at 24, 48, and 72 h after infection. For bacte-
rial burden determination, homogenized spleen, liver, lung, and 
kidney tissues were isolated from each individual mouse, serially 
diluted and spread on to LB agar plates.
Statistics
Student’s two-tailed t tests or Mann-Whitney tests were used, 
as well as one-way ANO VA test with Holm-Sidak correction for 
multiple comparisons.
Online supplemental material
Fig. S1 reports EYFP+ cell distribution in various tissues and 
EYFP-labeling efficiency of an alternate fate-mapping model. 
Fig. S2 shows confocal images of EYFP labeling in GCs. Fig. S3 
shows EYFP labeling of B cell subsets in the peritoneal cavity. 
Fig. S4 shows clonal distribution of VH sequences recovered 
after anti-CD20 depletion. Fig. S5 shows a schematic proposition 
of tissue contribution to the splenic IgM memory pool. Table S1 
shows mutation frequencies for the CD73+CD80+EYFP− IgM sub-
set; Table S2 shows VH characteristics of hybridoma sequences; 
and Table S3 shows antibody references.
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